Titration: In the event that further regulation of glycemic levels is required following a minimum of four weeks at the 0.5mg dosage, consider escalating the dose to 1mg weekly
For sourcing other peptides, see where to buy peptides in 2026
Key outcomes: Mean weight loss: 14.9% (vs 2.4% placebo) 86.4% of participants achieved 5% loss (vs 31.5% placebo) 50.5% achieved 15% loss (vs 4.9% placebo) SELECT (Lincoff et al., NEJM 2023) added the cardiovascular signature: in 17,604 non-diabetic adults with prior CV history, semaglutide 2.4 mg reduced MACE (CV death, MI, stroke) by 20% over 3 years
The modest rating volume means it should be treated as early marketplace feedback rather than strong validation
While these effects are usually temporary and improve as the body adjusts to the medication, its important to monitor changes and discuss persistent issues with a healthcare provider for medical advice
Heres where I want to be direct with you, because theres a lot of confusion online